Search Results

ML364 25 mg  | 100.00%

TargetMol

ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.

More Information Supplier Page

ML364 10 mg  | 100.00%

TargetMol

ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.

More Information Supplier Page

Y16 5 mg  | Purity Not Available

TargetMol

Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling functions.

More Information Supplier Page

Y16 10 mg  | Purity Not Available

TargetMol

Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling functions.

More Information Supplier Page

Epacadostat 5 mg  | 98.56%

TargetMol

Epacadostat is an oral-available inhibitor of indoleamine 2, 3-dioxygenase (IDO1), increasing the proliferation and activation of various immune cells and reducing tumor-associated regulatory T cells.

More Information Supplier Page

Epacadostat 50 mg  | 98.56%

TargetMol

Epacadostat is an oral-available inhibitor of indoleamine 2, 3-dioxygenase (IDO1), increasing the proliferation and activation of various immune cells and reducing tumor-associated regulatory T cells.

More Information Supplier Page

ML364 50 mg  | 100.00%

TargetMol

ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.

More Information Supplier Page

ML364 5 mg  | 100.00%

TargetMol

ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.

More Information Supplier Page